Abdi

Turkish pharma Abdi Ibrahim to invest $150 mln in 2021

Leading Turkish pharmaceutical firm Abdi Ibrahim is working to realize its $150 million investment plan in the imminent year, a senior company official said on Dec. 18. 

Süha Taşpolatoğlu, the CEO of Abdi Ibrahim, told Anadolu Agency that the firm will continue its domestic investments in 2021 and the new investments for production facilities will be on its agenda.